The secretome treatment utilizes a patient’s own biological material to create a blend of growth factors, peptides, and proteins. By leveraging these signaling molecules, the procedure seeks to improve hair quality and density by optimizing the follicular environment. For Dr. Kim Nichols, founder of the boutique dermatology practice, the addition represents a shift toward more tailored, regenerative care.

At The Hair Lab™, the new product joins a suite of existing services, including HydraScalp treatments and platelet-rich plasma therapy. Dr. Drew Taylor, CEO of Acorn Biolabs, developed the platform based on his research into hair follicle stem cells. During a recent visit to the Greenwich clinic, Taylor emphasized the role of autologous cells in future medical applications, noting that the secretome is designed to be a highly personalized component of a patient’s broader hair health strategy. Individuals interested in the treatment can undergo a scalp analysis at the clinic to determine if the procedure aligns with their specific aesthetic and medical goals.